Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
IronwoodIronwood(US:IRWD) Businesswire·2026-07-14 19:30

公司管理层变动 - Ironwood Pharmaceuticals 宣布首席医疗官兼研发负责人 Michael Shetzline 博士退休 [1] - 公司任命 Jeffrey Silber 博士为继任者，接替上述职位 [1] - Jeffrey Silber 博士将负责监督研究、药物开发、法规事务和医学事务部门 [1] 公司业务聚焦 - Ironwood Pharmaceuticals 是一家专注于胃肠道疾病和罕见病疗法的生物技术公司 [1]

Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients - Reportify